Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1534-1538, September 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, B. J.
Right arrow Articles by Yarbro, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, B. J.
Right arrow Articles by Yarbro, J. W.

Studies with Tritiated Mithramycin in C3H Mice1

B. J. Kennedy, Magnhild Sandberg-Wollheim, Merle Loken and John W. Yarbro

Departments of Medicine and Radiology, University of Minnesota Medical Center, Minneapolis, Minnesota 55455

The cytotoxic characteristics of the antibiotic mithramycin were studied by measuring the distribution of tritium-labeled mithramycin in C3H mice. The greatest concentrations of the isotope were in the kidneys and liver. The excretion of mithramycin-3H was rapid, and there was no evidence of metabolism of the carbohydrate moiety to carbon dioxide and water with loss through respiration. Although the concentration in the brain was low, the rate of fall of isotope activity was slower than in the other tissues. Radioautography studies demonstrated concentrations of the isotope in the Kupffer cells of the liver and cells of the renal tubules. The distribution of tritium-labeled mithramycin correlated closely with the known clinical, biochemical, and morphologic effects of administered mithramycin observed during the treatment of neoplasms of the testis, kidney, and brain.

1 This investigation was supported by Grants CA-3143, CA-05862, CA-08344, CA-08832, and T4 CA-5158 from the National Cancer Institute, USPHS.

Received 11/25/66. Accepted 5/ 2/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.